欢迎访问西安瑞禧生物技术有限公司官方网站

图片名

全国订购热线:
18966759382

首页 > 新闻资讯 > 行业新闻

行业新闻
行业新闻 市场活动 技术资讯

Ospemifene-d4,FC-1271a-d4「同位素标记抑制剂」

作者:瑞禧生物 发布时间:2025-06-18 10:16:10 次浏览

生物活性:Ospemifene-d4 is a deuterium labeled Ospemifene. Ospemifene is a selective and orally active estrogen receptor modulator for the prevention of osteoporosis with IC50 values of 827 nM and 1633 nM for estrogen receptor α (ERα) and ERβ, respectively. Ospemifene has bone-sparing, antitumor, and cholesterol-lowering effects[1][2].
IC50 & Target:IC50: 827 nM (estrogen receptor α (ERα)) and 1633 nM (ERβ)[1]
分子量:382.92
Formula:C24H19D4ClO2
非标记 CAS:128607-22-7
中文名称:奥培米芬 d4
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (531 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Qiang Qv.et al.Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Endocrinology.Feb;141(2):809-20. 25. (2000).
 [Content Brief]
[2]. Tracy L. Taras et al.In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 77(4-5):271-9,(2001).
 [Content Brief]